Rituximab Versus Tocilizumab in Anti-Tnf Inadequate Responder Patients with Rheumatoid Arthritis (R4RA): a Stratified, Biopsy-Driven, Multi-Centre, Randomised, Open Label, Controlled Clinical Trial – 16 Week Outcomes
Frances Humby,Patrick Durez,Maya H Buch,Myles Lewis, H.A. Rizvi,Felice Rivellese,Alessandra Nerviani,Giovanni Giorli,Arti Mahto, Carlomaurizio Montecucco,Bernard Lauwerys,Nora Ng,Pauline Ho,Michèle Bombardieri,Vasco C. Romão,Patrick Verschueren,Stephen Kelly,Pier Paolo Sainaghi,Nagui Gendi,Bhaskar Dasgupta,Alberto Cauli,Piero Reynolds,Juan D. Cañete, R. J. Moots,Peter C Taylor,Christopher J Edwards,John D. Isaacs, Peter Sasieni,Ernest Choy,Costantino Pitzalis Lancet（2020）
AI 理解论文
溯源树
样例
